MY148252A - 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines - Google Patents

6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines

Info

Publication number
MY148252A
MY148252A MYPI20041687A MYPI20041687A MY148252A MY 148252 A MY148252 A MY 148252A MY PI20041687 A MYPI20041687 A MY PI20041687A MY PI20041687 A MYPI20041687 A MY PI20041687A MY 148252 A MY148252 A MY 148252A
Authority
MY
Malaysia
Prior art keywords
alkylmethyl
cyclymethyl
substituted pyrazolopyrimidines
pyrazolopyrimidines
substituted
Prior art date
Application number
MYPI20041687A
Other languages
English (en)
Inventor
Martin Dr Hendrix
Lars Dr Barfacker
Christina Dr Erb
Frank-Thorsten Dr Hafner
Heike Dr Heckroth
Dagmar Schaus
Adrian Dr Tersteegen
Franz-Jozef Van Der Dr Staay
Marja Van Dr Kampen
Original Assignee
Boehringer Ingelheim Int
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Boehringer Ingelheim Int filed Critical Boehringer Ingelheim Int
Publication of MY148252A publication Critical patent/MY148252A/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychiatry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Plural Heterocyclic Compounds (AREA)
MYPI20041687A 2003-05-09 2004-05-07 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines MY148252A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
DE10320784 2003-05-09
DE10336183 2003-08-07
DE102004004142A DE102004004142A1 (de) 2003-05-09 2004-01-28 6-Cyclylmethyl- und 6-Alkylmethyl-substituierte Pyrazolopyrimidine

Publications (1)

Publication Number Publication Date
MY148252A true MY148252A (en) 2013-03-29

Family

ID=33420016

Family Applications (1)

Application Number Title Priority Date Filing Date
MYPI20041687A MY148252A (en) 2003-05-09 2004-05-07 6-cyclymethyl-and 6-alkylmethyl-substituted pyrazolopyrimidines

Country Status (9)

Country Link
EP (1) EP2298773B1 (enExample)
JP (1) JP5277303B2 (enExample)
CL (1) CL2004000978A1 (enExample)
DE (1) DE102004004142A1 (enExample)
MY (1) MY148252A (enExample)
NZ (1) NZ543812A (enExample)
PE (1) PE20050201A1 (enExample)
RU (1) RU2383546C2 (enExample)
TW (1) TWI350836B (enExample)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102234131B1 (ko) * 2013-04-05 2021-04-01 에자이 알앤드디 매니지먼트 가부시키가이샤 피리디닐피라졸로퀴놀린 화합물
KR20200010211A (ko) 2017-06-01 2020-01-30 에자이 알앤드디 매니지먼트 가부시키가이샤 Pde9 저해제를 포함하는 약제학적 조성물
AU2018276565A1 (en) 2017-06-01 2019-11-07 Eisai R&D Management Co., Ltd. Dementia therapeutic agent combining pyrazoloquinoline derivative and donepezil
AU2018276568A1 (en) 2017-06-01 2019-11-07 Eisai R&D Management Co., Ltd. Dementia therapeutic agent combining pyrazoloquinoline derivative and memantine
TWI784006B (zh) 2017-06-01 2022-11-21 日商衛材R&D企管股份有限公司 含有吡唑并喹啉衍生物之路易氏體症治療劑

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH396924A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung von 4-Mercapto-pyrazolo(3,4-d)pyrimidinen
CH396926A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
CH396927A (de) 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
CH396925A (de) * 1960-05-11 1965-08-15 Ciba Geigy Verfahren zur Herstellung neuer Pyrazolopyrimidine
DE1147234B (de) 1960-05-11 1963-04-18 Ciba Geigy Verfahren zur Herstellung von 1-Isopropyl-4-hydroxy-6-benzyl-pyrazolo[3, 4-d]pyrimidin
DE1149013B (de) 1960-05-11 1963-05-22 Ciba Geigy Verfahren zur Herstellung von 4-Oxo-4, 5-dihydro-pyrazolo-[3, 4-d]Pyrimidinen
DE1161281B (de) 1960-05-11 1964-01-16 Ciba Aktiengesellschaft, Basel (Schweiz) Verfahren zur Herstellung von 1-Alkyl-6-aralkyl-pyrazoloÄ3,4-dÜ-pyrimidinen.
US3732225A (en) 1970-07-23 1973-05-08 Squibb & Sons Inc Pyrazolo(3,4-d)pyrimidine derivatives
US3847908A (en) 1973-03-05 1974-11-12 Squibb & Sons Inc 6-styrylpyrazolo(3,4-d)pyrimidinones and pyrimidines
ATE126207T1 (de) 1989-01-26 1995-08-15 Bayer Ag Optisch aktive (meth)acrylsäure-derivate, ihre herstellung, ihre polymerisation zu optisch aktiven polymeren und deren verwendung.
RU2104216C1 (ru) * 1994-01-10 1998-02-10 Акционерное общество открытого типа "Таганрогский авиационный научно-технический комплекс им.Г.М.Бериева" Замок
DE19709877A1 (de) 1997-03-11 1998-09-17 Bayer Ag 1,5-Dihydro-pyrazolo[3,4-d]-pyrimidinon-derivate
ES2233685T3 (es) * 2000-08-01 2005-06-16 Bayer Healthcare Ag Inhibidores selectivos de pde 2 como medicamentos para mejorar la percepcion.
HUP0401998A2 (hu) * 2001-11-02 2005-01-28 Pfizer Products Inc., PDE9 inhibitorok alkalmazása olyan gyógyszer előállítására, amellyel inzulin-rezisztencia szindróma és 2-es típusú diabétesz kezelhető
HN2002000317A (es) * 2001-11-02 2003-05-21 Pfizer Inhibidores de pde9 para tratamiento de trastornos cardiovasculares
DE10219435A1 (de) * 2002-05-02 2003-11-13 Bayer Cropscience Ag Substituierte Pyrazolo-pyrimidin-4-one

Also Published As

Publication number Publication date
DE102004004142A1 (de) 2004-11-25
NZ543812A (en) 2010-06-25
RU2005138339A (ru) 2006-08-10
CL2004000978A1 (es) 2005-03-18
JP2012036221A (ja) 2012-02-23
RU2383546C2 (ru) 2010-03-10
EP2298773B1 (de) 2013-06-19
PE20050201A1 (es) 2005-05-27
EP2298773A1 (de) 2011-03-23
TWI350836B (en) 2011-10-21
TW200508237A (en) 2005-03-01
JP5277303B2 (ja) 2013-08-28

Similar Documents

Publication Publication Date Title
WO2003055878A8 (de) 2-heteroarylcarbonsäureamide
WO2003078431A8 (de) Aza- bicyclische n-biarylamide mit affinität zum alpha7 nikotinischen acetylcholin-rezeptor
IL173204A0 (en) Novel cyanopyrrolidides, methods for the production thereof, and use of the same as medicaments
TW200738270A (en) Method of treating depression using a TNFα antibody
TW200505875A (en) Novel compounds
TW200801002A (en) 8-(3-amino-piperidin-1-yl)-xanthines, their preparation and their use as pharmacon
IL180874A0 (en) Substituted, bicyclic 8-pyrrolidinoxanthines, method for the production thereof and their use as medicaments
PL1654253T3 (pl) Podstawione pochodne 3-pirolidynoindolu
WO2004026286A3 (de) Selektive phosphodiesterase 9a-inhibitoren als arzneimittel zur verbesserung kognitiver prozesse
MXPA05008478A (es) Heterociclos sustituidos.
DE50305587D1 (en) 2-heteroarylcarbonsäureamide
TW200510344A (en) Aryl-heteroaromatic products, compositions comprising them and use
MX2007002470A (es) Fenilaminotiazoles sustituidos y su uso.
WO2006009765A3 (en) Methods for the identification and use of compounds suitable for the treatment of drug resistant cancer cells
PL1928836T3 (pl) Podstawione 4-fenylotetrahydroizochinoliny, sposób ich wytwarzania, zastosowanie jako lek oraz lek je zawierający
WO2004043379A3 (en) Chemical compounds
TW200510449A (en) Acylated nonadepsipeptides
BR0209541A (pt) Uso das imidazotriazinonas 2-fenil-substituìdas
WO2004031202A3 (de) Kondensierte palatinose in hydrierter form
MY149864A (en) Flavouring-containing pharmaceutical formulations with improved pharmaceutical properties
EP1505139A4 (en) THICKENERS, THIS INCLUDING COSMETICS AND ITS MANUFACTURING PROCESS
WO2005010165A3 (en) Non-glycosylated human alpha-fetoprotein, methods of production, and uses thereof
MXPA04000446A (es) 4-aminociclohexanoles sustituidos.
TW200621799A (en) Acylated nonadepsipeptides II
AU2003262026A1 (en) Method of producing structural body that functions as seat, backrest, partition, etc., and structural body produced by the method